tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chris Shibutani, 82 are a BUY (56.94%), 57 are a HOLD (39.58%), 5 are a SELL (3.47%).
Analyst Chris Shibutani, carries an average stock price target met ratio of 59.8% that have a potential upside of 19.32% achieved within 196 days. Previously, Chris Shibutani worked at GOLDMAN SACHS.
Chris Shibutani’s has documented 291 price targets and ratings displayed on 35 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SDGR, Schrodinger at 30-Sep-2025.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $117 was fulfilled within 1 day with a profit of $21.2 (22.13%) receiving and performance score of 221.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$35
$3.94 (12.69%)
$34
29 days ago
(08-Sep-2025)
8/9 (88.89%)
$7.15 (25.67%)
112
Hold
$46
$14.94 (48.10%)
$46
29 days ago
(08-Sep-2025)
19/25 (76%)
$18.15 (65.17%)
295
Buy
$45
$13.94 (44.88%)
$45
2 months 9 days ago
(28-Jul-2025)
0/3 (0%)
$18 (66.67%)
Buy
$42
$10.94 (35.22%)
$38
3 months 21 days ago
(16-Jun-2025)
2/4 (50%)
$12.23 (41.08%)
86
Buy
$41
$9.94 (32.00%)
$38
5 months 6 days ago
(01-May-2025)
0/2 (0%)
$9.22 (29.01%)
Which stock is Chris Shibutani is most bullish on?
Which stock is Chris Shibutani is most reserved on?
What Year was the first public recommendation made by Chris Shibutani?
